These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15863313)

  • 1. A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.
    Pontillo J; Tran JA; Markison S; Joppa M; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Nelson J; Saunders J; Hoare SR; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 May; 15(10):2541-6. PubMed ID: 15863313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of piperazinebenzylamines with a N-(1-methoxy-2-propyl) side chain as potent and selective antagonists of the human melanocortin-4 receptor.
    Pontillo J; Marinkovic D; Tran JA; Arellano M; Fleck BA; Wen J; Tucci FC; Nelson J; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4615-8. PubMed ID: 16105734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Fleck BA; Marinkovic D; Arellano M; Tucci FC; Lanier M; Nelson J; Parker J; Saunders J; Murphy B; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5605-9. PubMed ID: 15482933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of agonists and antagonists of the human melanocortin-4 receptor from piperazinebenzylamines.
    Tran JA; Pontillo J; Arellano M; White NS; Fleck BA; Marinkovic D; Tucci FC; Lanier M; Nelson J; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Feb; 15(3):833-7. PubMed ID: 15664867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.
    Chen C; Tucci FC; Jiang W; Tran JA; Fleck BA; Hoare SR; Wen J; Chen T; Johns M; Markison S; Foster AC; Marinkovic D; Chen CW; Arellano M; Harman J; Saunders J; Bozigian H; Marks D
    Bioorg Med Chem; 2008 May; 16(10):5606-18. PubMed ID: 18417348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.
    Fotsch C; Han N; Arasasingham P; Bo Y; Carmouche M; Chen N; Davis J; Goldberg MH; Hale C; Hsieh FY; Kelly MG; Liu Q; Norman MH; Smith DM; Stec M; Tamayo N; Xi N; Xu S; Bannon AW; Baumgartner JW
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1623-7. PubMed ID: 15745810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor.
    Tran JA; Jiang W; Tucci FC; Fleck BA; Wen J; Sai Y; Madan A; Chen TK; Markison S; Foster AC; Hoare SR; Marks D; Harman J; Chen CW; Arellano M; Marinkovic D; Bozigian H; Saunders J; Chen C
    J Med Chem; 2007 Dec; 50(25):6356-66. PubMed ID: 17994683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazines.
    Tucci FC; White NS; Markison S; Joppa M; Tran JA; Fleck BA; Madan A; Dyck BP; Parker J; Pontillo J; Arellano LM; Marinkovic D; Jiang W; Chen CW; Gogas KR; Goodfellow VS; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4389-95. PubMed ID: 16098742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.
    Chen C; Pontillo J; Fleck BA; Gao Y; Wen J; Tran JA; Tucci FC; Marinkovic D; Foster AC; Saunders J
    J Med Chem; 2004 Dec; 47(27):6821-30. PubMed ID: 15615531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.
    Pontillo J; Tran JA; Arellano M; Fleck BA; Huntley R; Marinkovic D; Lanier M; Nelson J; Parker J; Saunders J; Tucci FC; Jiang W; Chen CW; White NS; Foster AC; Chen C
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4417-23. PubMed ID: 15357964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor.
    Tran JA; Pontillo J; Arellano M; Fleck BA; Tucci FC; Marinkovic D; Chen CW; Saunders J; Foster AC; Chen C
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3434-8. PubMed ID: 15950470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocortin peptides affect the motivation to feed in rainbow trout (Oncorhynchus mykiss).
    Schjolden J; Schiöth HB; Larhammar D; Winberg S; Larson ET
    Gen Comp Endocrinol; 2009 Jan; 160(2):134-8. PubMed ID: 19027741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic-like effect of a selective and non-peptidergic melanocortin 4 receptor antagonist, MCL0129, in a social interaction test.
    Shimazaki T; Chaki S
    Pharmacol Biochem Behav; 2005 Mar; 80(3):395-400. PubMed ID: 15740781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the melanocortin receptor stimulation or inhibition on ethanol intake in alcohol-preferring rats.
    Polidori C; Geary N; Massi M
    Peptides; 2006 Jan; 27(1):144-9. PubMed ID: 16198024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice.
    Nicholson JR; Kohler G; Schaerer F; Senn C; Weyermann P; Hofbauer KG
    J Pharmacol Exp Ther; 2006 May; 317(2):771-7. PubMed ID: 16436498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonists.
    Chen C; Yu J; Fleck BA; Hoare SR; Saunders J; Foster AC
    J Med Chem; 2004 Jul; 47(16):4083-8. PubMed ID: 15267247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel piperazines: potent melanocortin-4 receptor antagonists with anxiolytic-like activity.
    Nozawa D; Okubo T; Ishii T; Takamori K; Chaki S; Okuyama S; Nakazato A
    Bioorg Med Chem; 2007 Mar; 15(6):2375-85. PubMed ID: 17267226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.
    Tian X; Mishra RK; Switzer AG; Hu XE; Kim N; Mazur AW; Ebetino FH; Wos JA; Crossdoersen D; Pinney BB; Farmer JA; Sheldon RJ
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4668-73. PubMed ID: 16766182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.
    Chen C; Jiang W; Tran JA; Tucci FC; Fleck BA; Markison S; Wen J; Madan A; Hoare SR; Foster AC; Marinkovic D; Chen CW; Arellano M; Saunders J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):129-36. PubMed ID: 18032040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.